Tari A, King, MD, chief of Breast Surgery has been promoted to professor of surgery at Harvard Medical School.
Tari A. King, MD
Anne E. Dyson Professor of Surgery in the Field of Women’s Cancers, Harvard Medical School
Chief, Division of Breast Surgery, Dana-Farber/Brigham and Women’s Cancer Center
Associate Chair of Multidisciplinary Oncology, Department of Surgery, Brigham and Women’s Hospital
Director, Breast Cancer Personalized Risk Assessment, Education and Prevention (B-PREP) Program, Brigham and Women’s Hospital
Dr. King is chief of the Division of Breast Surgery at Dana-Farber/Brigham and Women’s Cancer Center and the Anne E. Dyson Professor of Surgery in the Field of Women’s Cancers at Harvard Medical School. She serves as the associate chair of Multidisciplinary Oncology in the Department of Surgery as well as the director of the Breast Cancer Personalized Risk Assessment, Education and Prevention (B-PREP) Program at the Brigham.
Dr. King received her medical degree from University of Colorado Health Sciences Center and completed a general surgery residency at Ochsner Clinic Foundation Hospital (now Ochsner Medical Center). Dr. King completed both a surgical research fellowship and a breast surgery clinical fellowship at Memorial Sloan Kettering Cancer Center. Her clinical and research efforts focus on improving clinical management strategies for women at high risk of developing breast cancer with a special emphasis on lobular carcinoma in situ and atypical hyperplasia. She also has an interest in the role of surgery in stage IV breast cancer and through the Translational Breast Cancer Research Consortium (TBCRC) she successfully initiated and completed accrual to a multi-center trial addressing this issue.
She has received several awards to support her work on high-risk breast lesions, including the Society of Surgical Oncology (SSO) Clinical Investigator Award in Breast Cancer Research (2008), a Career Catalyst Research Award (2009), an Investigator-Initiated Research Award (2012) and a leadership grant from the Susan G. Komen for the Cure Foundation (2016). Most recently, she was awarded a development grant from the Brigham Precision Medicine Program (2018-19).
Dr. King currently serves on the Steering Committee for the Translational Breast Cancer Research Consortium (TBCRC), the National Institute of Cancer (NCI) Breast Oncology Local Disease (BOLD) Task Force and the 2019 American Association for Cancer Research (AACR) Cancer Progress Report. She is also a member of the Executive Council and the chair of the Quality Committee for the Society of Surgical Oncology (SSO).